SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019930
Filing Date
2018-08-07
Accepted
2018-08-07 16:12:07
Documents
58
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-10q_20180630.htm 10-Q 1450863
2 EX-31.1 arwr-ex311_9.htm EX-31.1 10488
3 EX-31.2 arwr-ex312_7.htm EX-31.2 10933
4 EX-32.1 arwr-ex321_6.htm EX-32.1 6315
5 EX-32.2 arwr-ex322_8.htm EX-32.2 6562
  Complete submission text file 0001564590-18-019930.txt   4686644

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arwr-20180630.xml EX-101.INS 696921
7 XBRL TAXONOMY EXTENSION SCHEMA arwr-20180630.xsd EX-101.SCH 40972
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20180630_cal.xml EX-101.CAL 46705
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20180630_def.xml EX-101.DEF 146646
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20180630_lab.xml EX-101.LAB 360496
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20180630_pre.xml EX-101.PRE 278865
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 18998096
SIC: 2834 Pharmaceutical Preparations